ATYR
aTyr Pharma, Inc.
0.3376$
-10.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 85.8% | 85.4% | 85.6% | 85.2% | 83.3% | 84.6% | 85.6% | 86.2% | 87.2% | 85.2% | 84.8% | 83.6% | |
| 7.8% | 18.7% | 6.0% | 6.4% | 12.5% | 11.4% | 10.7% | 17.0% | 5.8% | 11.4% | 12.6% | 23.1% | |
| 81.7% | 81.4% | 74.6% | 74.1% | 72.0% | 74.5% | 78.5% | 79.1% | 84.6% | 83.6% | 83.5% | 82.2% | |
| 1.7% | 2.0% | 2.2% | 1.5% | 2.0% | 1.8% | 1.0% | 0.5% | 1.0% | 0.9% | 0.6% | 0.6% | |
| 21.5% | 25.0% | 25.6% | 23.1% | 28.9% | 27.9% | 23.0% | 26.5% | 24.9% | 28.5% | 27.5% | 30.4% | |
| 10.3% | 13.6% | 14.1% | 11.2% | 15.4% | 15.5% | 11.0% | 15.3% | 14.7% | 16.1% | 14.7% | 16.3% | |
| 1.0% | 1.1% | 1.0% | 1.1% | 1.3% | 1.3% | 1.3% | 1.3% | 1.3% | 1.6% | 1.9% | 2.1% | |
| 1.6% | 2.9% | 4.3% | 1.2% | 4.3% | 4.5% | 1.6% | 3.8% | 3.8% | 4.1% | 3.5% | 4.6% | |
| 78.7% | 75.1% | 74.6% | 77.0% | 71.3% | 72.3% | 77.2% | 73.7% | 75.2% | 71.7% | 72.7% | 69.9% | |
| -362.4% | -387.9% | -426.9% | -471.8% | -564.4% | -549.5% | -562.4% | -557.9% | -555.3% | -643.7% | -774.5% | -898.3% | |
| 46.3% | 49.1% | 58.3% | 68.2% | 82.7% | 85.4% | 88.9% | 88.8% | 91.1% | 104.1% | 123.1% | 140.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.